🏛️ Verified NIH Protocol • Sourced via U.S. National Library of Medicine (Last Synced: 2024-12-20)

Angiotensin Receptor Blockers in Aortic Stenosis

🟢 Recruiting Phase 4 💊 Investigational Drug / Biologic Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

🩺 Protocol Summary

This study is intended to investigate the effect of angiotensin receptor blockers (ARBs) on mild-to-moderate aortic stenosis.

Primary Research Facility: CRIUCPQ (Québec, Quebec)

📋 Basic Study Criteria & Logistics Checklist

0 of 3 Checked

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Aortic Stenosis?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged between 20 Years and 99 Years?

🔍 Protocol Specified Age Range: 20 Years to 99 Years

Able to attend required in-person clinic visits and study procedures at one of the participating study centers?

🔍 Logistical Requirement: 2 Registered Participating Sites

📍 Primary Site Map

Site: CRIUCPQ — Québec, Quebec

📍 All Participating Trial Locations (2 Sites)

Multi-Center Trial

This protocol is enrolling participants across multiple clinical centers:

1. CRIUCPQ — Québec, Quebec • Contact: (418) 656-8711

2. Odense University Hospital — United States • Contact: (456) 067-7621

📄 Print Doctor Discussion Sheet

Preview and print a 1-page summary with 5 tailored questions for your physician.

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.

🏛️ Official Government Provenance

NIH ClinicalTrials.gov Protocol Record

NCT Identifier: NCT04913870 • Last Synced: 2024-12-20

View on ClinicalTrials.gov ↗